Francois Brisebois
Stock Analyst at Oppenheimer
(1.10)
# 3,594
Out of 4,855 analysts
89
Total ratings
29.55%
Success rate
-14.74%
Average return
Main Sectors:
Stocks Rated by Francois Brisebois
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| SNSE Sensei Biotherapeutics | Maintains: Outperform | $3.5 → $4 | $0.34 | +1,062.12% | 2 | Mar 28, 2025 | |
| ABEO Abeona Therapeutics | Initiates: Outperform | $16 | $6.74 | +137.39% | 1 | Mar 5, 2025 | |
| OVID Ovid Therapeutics | Upgrades: Outperform | $4 | $0.32 | +1,155.49% | 1 | Jan 29, 2025 | |
| TARS Tarsus Pharmaceuticals | Maintains: Outperform | $65 → $72 | $43.84 | +64.24% | 7 | Jan 22, 2025 | |
| MNMD Mind Medicine (MindMed) | Reiterates: Outperform | $20 | $7.79 | +156.74% | 4 | Dec 17, 2024 | |
| TRDA Entrada Therapeutics | Maintains: Outperform | $25 → $28 | $8.35 | +235.33% | 2 | Nov 6, 2024 | |
| AVDL Avadel Pharmaceuticals | Maintains: Outperform | $29 → $30 | $9.72 | +208.64% | 8 | Oct 31, 2024 | |
| PRAX Praxis Precision Medicines | Maintains: Outperform | $143 → $163 | $44.59 | +265.55% | 4 | Oct 31, 2024 | |
| HRMY Harmony Biosciences Holdings | Reiterates: Outperform | $56 → $59 | $35.57 | +65.87% | 5 | Oct 30, 2024 | |
| DYN Dyne Therapeutics | Reiterates: Outperform | $55 | $14.70 | +274.15% | 5 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $15 | $4.14 | +262.32% | 2 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $6 | $4.16 | +44.40% | 5 | Aug 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $11 | $3.83 | +187.21% | 6 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $14 | $11.92 | +17.45% | 2 | Aug 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $11 → $15 | $2.44 | +514.75% | 4 | Jun 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $25 | $2.83 | +783.39% | 1 | Jun 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $55 → $65 | $27.55 | +135.93% | 5 | Jun 13, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $10 | $2.66 | +275.94% | 2 | May 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $5 | $0.54 | +824.21% | 3 | Apr 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Outperform | $152 | $8.90 | +1,607.87% | 2 | Aug 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $63 → $36 | $21.59 | +66.78% | 4 | Aug 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $5 → $4 | $3.91 | +2.43% | 3 | Apr 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $100 → $60 | $0.30 | +19,860.08% | 3 | Apr 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $7,200 → $5,400 | $3.75 | +143,900.00% | 2 | Feb 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $8.5 | $3.56 | +138.76% | 1 | Sep 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $17 → $11 | $1.55 | +609.68% | 2 | Aug 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Outperform | $18 | $2.07 | +769.57% | 1 | Jul 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $50 | $4.80 | +941.67% | 1 | Oct 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $3,240 | $1.51 | +214,469.54% | 1 | Feb 4, 2020 | |
Sensei Biotherapeutics
Mar 28, 2025
Maintains: Outperform
Price Target: $3.5 → $4
Current: $0.34
Upside: +1,062.12%
Abeona Therapeutics
Mar 5, 2025
Initiates: Outperform
Price Target: $16
Current: $6.74
Upside: +137.39%
Ovid Therapeutics
Jan 29, 2025
Upgrades: Outperform
Price Target: $4
Current: $0.32
Upside: +1,155.49%
Tarsus Pharmaceuticals
Jan 22, 2025
Maintains: Outperform
Price Target: $65 → $72
Current: $43.84
Upside: +64.24%
Mind Medicine (MindMed)
Dec 17, 2024
Reiterates: Outperform
Price Target: $20
Current: $7.79
Upside: +156.74%
Entrada Therapeutics
Nov 6, 2024
Maintains: Outperform
Price Target: $25 → $28
Current: $8.35
Upside: +235.33%
Avadel Pharmaceuticals
Oct 31, 2024
Maintains: Outperform
Price Target: $29 → $30
Current: $9.72
Upside: +208.64%
Praxis Precision Medicines
Oct 31, 2024
Maintains: Outperform
Price Target: $143 → $163
Current: $44.59
Upside: +265.55%
Harmony Biosciences Holdings
Oct 30, 2024
Reiterates: Outperform
Price Target: $56 → $59
Current: $35.57
Upside: +65.87%
Dyne Therapeutics
Sep 3, 2024
Reiterates: Outperform
Price Target: $55
Current: $14.70
Upside: +274.15%
Aug 19, 2024
Reiterates: Outperform
Price Target: $15
Current: $4.14
Upside: +262.32%
Aug 16, 2024
Reiterates: Outperform
Price Target: $6
Current: $4.16
Upside: +44.40%
Aug 15, 2024
Reiterates: Outperform
Price Target: $11
Current: $3.83
Upside: +187.21%
Aug 14, 2024
Reiterates: Outperform
Price Target: $14
Current: $11.92
Upside: +17.45%
Jun 26, 2024
Maintains: Outperform
Price Target: $11 → $15
Current: $2.44
Upside: +514.75%
Jun 25, 2024
Initiates: Outperform
Price Target: $25
Current: $2.83
Upside: +783.39%
Jun 13, 2024
Maintains: Outperform
Price Target: $55 → $65
Current: $27.55
Upside: +135.93%
May 6, 2024
Reiterates: Outperform
Price Target: $10
Current: $2.66
Upside: +275.94%
Apr 1, 2024
Reiterates: Outperform
Price Target: $5
Current: $0.54
Upside: +824.21%
Aug 30, 2023
Reiterates: Outperform
Price Target: $152
Current: $8.90
Upside: +1,607.87%
Aug 17, 2023
Maintains: Outperform
Price Target: $63 → $36
Current: $21.59
Upside: +66.78%
Apr 4, 2023
Maintains: Outperform
Price Target: $5 → $4
Current: $3.91
Upside: +2.43%
Apr 3, 2023
Maintains: Outperform
Price Target: $100 → $60
Current: $0.30
Upside: +19,860.08%
Feb 6, 2023
Maintains: Outperform
Price Target: $7,200 → $5,400
Current: $3.75
Upside: +143,900.00%
Sep 7, 2022
Initiates: Outperform
Price Target: $8.5
Current: $3.56
Upside: +138.76%
Aug 29, 2022
Maintains: Outperform
Price Target: $17 → $11
Current: $1.55
Upside: +609.68%
Jul 18, 2022
Assumes: Outperform
Price Target: $18
Current: $2.07
Upside: +769.57%
Oct 29, 2021
Initiates: Outperform
Price Target: $50
Current: $4.80
Upside: +941.67%
Feb 4, 2020
Initiates: Buy
Price Target: $3,240
Current: $1.51
Upside: +214,469.54%